RNU4ATAC and Roifman syndrome: In addition, Roifman Syndrome causal variants always present a characteristic compound heterozygosity pattern: one variant affects RNU4ATAC elements already implicated in MOPD1, while the other variant affects a newly disease-implicated yet highly conserved element, the stem II.